HONG KONG – Celltrion Inc. has much to look forward to in the European market, where perception on biosimilars is shifting for the better. The Congress of the European Crohn's and Colitis Organisation announced its support for switching from reference Remicade (infliximab, Janssen Biotech Inc.), the blockbuster anti-inflammatory drug, to biosimilar infliximab.
HONG KONG – Sanofi SA entered a strategic alliance with Taiwan's JHL Biotech, Inc. which could provide a cash infusion and speed up the commercialization of JHL Biotech's biosimilar drugs in China.
HONG KONG – Eutilex Co. Ltd. has raised $18 million in a series A financing, the largest private funding round for a startup in South Korea's life sciences sector.
HONG KONG – Eutilex Co. Ltd. has raised $18 million in a series A financing, the largest private funding round for a startup in South Korea’s life sciences sector.
HONG KONG – Sanofi SA entered a strategic alliance with Taiwan's JHL Biotech, Inc. which could provide a cash infusion and speed up the commercialization of JHL Biotech's biosimilar drugs in China.
SINGAPORE – The wearable med-tech space saw a heated flurry of activity over the last year across Asia, but enthusiasm has cooled considerably as the obstacles that lie ahead for the sector become more apparent. Panelists speaking during the Asia Pacific Medtech Forum 2016 in Singapore emphasized that wearables will have to influence consumer behavior if they are to stay relevant. "If you look at wearables now, they are not medical-grade devices. It's very difficult for hospitals and practitioners to use them. From a start up point of view, we need to step up to...
SINGAPORE – The wearable med-tech space saw a heated flurry of activity over the last year across Asia, but enthusiasm has cooled considerably as the obstacles that lie ahead for the sector become more apparent.
